-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – Gene Therapy For Multiple Myeloma And Stem Cell Transplantation in Stem Cell Transplantation
OverviewHow likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data.Gene Therapy For Multiple Myeloma And Stem Cell Transplantation in Stem Cell TransplantationDrug Details:Gene therapy is...
-
Company Insights
New![]()
Innovation and Patenting activity of Stem Inc Q3 2023
GlobalData, the industry analysis specialist, has released its latest company patent databook "Innovation and Patenting activity of Stem Inc Q3 2023". The databook highlights patenting activity of the company in terms of growth in filings and grants, regions protected, impact of various themes, sector applicability of technologies protected. It provides contextual analysis of technical peers, their strategy, dominance (Grant share) and their recent activities. This is an on-demand databook that will be delivered upon request. The report will be delivered...
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – IMM01-STEM in Muscle Atrophy
OverviewHow likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data.IMM01-STEM in Muscle AtrophyDrug Details:IMM01-STEM is under development for the treatment of muscle atrophy related to...
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – Allorx Stem Cell Therapy in Inflammation
Overview How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Allorx Stem Cell Therapy in Inflammation Drug Details: Stem cell therapy is under development...
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – Trecondyv in Hematopoietic Stem Cell Transplantation
Overview How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Trecondyv in Hematopoietic Stem Cell Transplantation Drug Details: Treosulfan (Trecondyv, Trecondi) is the prodrug...
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – FR-104 in Stem Cell Transplantation
OverviewHow likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalDatas proprietary machine learning algorithms developed using over 10 years of historical data.FR-104 in Stem Cell Transplantation Drug Details:FR-104 is under development for the treatment of autoimmune disorders...
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – Sargramostim in Hematopoietic Stem Cell Transplantation
How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data. Sargramostim in Hematopoietic Stem Cell Transplantation Drug Details: Sargramostim (Leukine, Interberin) is a recombinant granulocyte...
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – Umbilical Cord Mesenchymal Stem Cells in Injury
How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data. Umbilical Cord Mesenchymal Stem Cells in Injury Drug Details: Stem cell therapy is under development...
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – Mesenchymal Stem Cells-Derived Exosomes in Dermatomyositis
How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data.Mesenchymal Stem Cells-Derived Exosomes in Dermatomyositis Drug Details: The drug candidate is under development for the...
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – Neuron Stem Cells (Insc) in Ischemic Stroke
OverviewHow likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data.Neuron Stem Cells (Insc) in Ischemic StrokeDrug Details:Stem cell therapy is under development for the treatment...
Sign up to receive regular alerts for our latest analysis and reports. No matter your industry focus, you can keep your finger on the pulse with our timely updates.